Windlas Biotech Limited Financial Flexibility Index
Windlas Biotech Limited financial flexibility index. Windlas Biotech Limited (WINDLAS) has a Financial Flexibility Index of 0.04x as of September 2023. Free cash flow of Rs66.60 Million (operating CF Rs66.60 Million minus capex Rs0.00) represents 0% of total liabilities (Rs1.54 Billion). See Windlas Biotech Limited free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Windlas Biotech Limited (2018–2025)
Financial flexibility index of Windlas Biotech Limited from 2018 to 2025. Historical Financial Flexibility Index trend for Windlas Biotech Limited across 8 annual periods. Check Windlas Biotech Limited (WINDLAS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Windlas Biotech Limited Financial Flexibility Index by Year (2018–2025)
Windlas Biotech Limited financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Windlas Biotech Limited. For the full cash flow conversion analysis, see WINDLAS cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.47x | Rs1.20 Billion | Rs681.87 Million | Rs2.55 Billion | ▼ -43.2% |
| 2024 | 0.83x | Rs1.47 Billion | Rs1.09 Billion | Rs1.76 Billion | ▼ -20.1% |
| 2023 | 1.04x | Rs1.32 Billion | Rs609.65 Million | Rs1.27 Billion | ▲ +318.4% |
| 2022 | 0.25x | Rs239.34 Million | Rs91.30 Million | Rs962.33 Million | ▲ +39.4% |
| 2021 | 0.18x | Rs173.01 Million | Rs114.54 Million | Rs970.04 Million | ▼ -43.0% |
| 2020 | 0.31x | Rs403.16 Million | Rs250.06 Million | Rs1.29 Billion | ▲ +18.6% |
| 2019 | 0.26x | Rs276.08 Million | Rs186.54 Million | Rs1.05 Billion | ▼ -21.4% |
| 2018 | 0.34x | Rs553.73 Million | Rs295.91 Million | Rs1.65 Billion | — |